UFPT trades 9.4% below Wall Street's consensus target of $298.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes UFPT achieves its forward estimates and maintains a stable P/E multiple of 28.7x. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 6, 2026, UFP Technologies, Inc. (UFPT) has a Wall Street consensus price target of $298.00, based on estimates from 2 covering analysts. With the stock currently trading at $272.36, this represents a potential upside of +9.4%. The company has a market capitalization of $2.11B.
Analyst price targets range from a low of $252.00 to a high of $344.00, representing a 31% spread in expectations. The median target of $298.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, UFPT trades at a trailing P/E of 31.1x and forward P/E of 28.7x. The forward PEG ratio of 0.76 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +8.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $291.42, with bear and bull scenarios of $183.59 and $383.97 respectively. Model confidence stands at 51/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
PFBCPreferred Bank | $1.3B | $107.16 | $102.00 | -4.8% | Buy | 10.0x | 10 |
CPACCementos Pacasmayo S.A.A. | $1.0B | $11.92 | $12.80 | +7.4% | Hold | 8.2x | 8 |
ITGRInteger Holdings Corporation | $3.3B | $95.14 | $108.00 | +13.5% | Buy | 15.6x | 15 |
NNBRNN, Inc. | $184M | $3.49 | — | — | Buy | 53.7x | 9 |
ESABESAB Corporation | $5.6B | $92.78 | $138.25 | +49.0% | Buy | 16.1x | 10 |
LGNDLigand Pharmaceuticals Incorporated | $6.4B | $319.55 | $265.33 | -17.0% | Buy | 35.3x | 17 |
SEESealed Air Corporation | $6.2B | $42.15 | $49.92 | +18.4% | Buy | 12.4x | 27 |
SLGNSilgan Holdings Inc. | $4.9B | $46.39 | $50.50 | +8.9% | Buy | 12.2x | 21 |
PACKRanpak Holdings Corp. | $560M | $6.55 | $9.38 | +43.2% | Buy | — | 5 |
LYBLyondellBasell Industries N.V. | $17.2B | $53.36 | $79.40 | +48.8% | Hold | 5.8x | 39 |
Quick answers to the most common questions about buying UFPT stock.
The consensus price target for UFPT is $298, close to the current price of $272.36 (9.4% implied move). Based on 2 analyst estimates, the stock appears fairly valued near current levels.
UFPT has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $298 implies 9.4% upside from current levels.
UFPT trades at a forward P/E of 28.6619x, representing a moderate valuation. With analysts targeting $298 (9.4% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $344 for UFPT, while the most conservative target is $252. The consensus of $298 represents the median expectation. Our quantitative valuation model projects a bull case target of $384 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
UFPT is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month UFPT stock forecast based on 2 Wall Street analysts shows a consensus price target of $298, with estimates ranging from $252 (bear case) to $344 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $291, with bear/bull scenarios of $184/$384.
Our quantitative valuation model calculates UFPT's fair value at $291 (base case), with a bear case of $184 and bull case of $384. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.
UFPT trades at a forward P/E ratio of 28.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 31.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
UFPT appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $298 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
UFPT analyst price targets range from $252 to $344, a 31% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $298 consensus represents the middle ground. Our model's $184-$384 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.